Inflammatory response in an immunosuppressed patient with Wegener's granulomatosis

Perfusion

Volumn 19, Issue 2, 2004, Pages 127-131

  Mirsadraee, Saeed ^a   Fraser, Alexander ^a   Kerr, Michael A ^a   James, Teifi E ^b   van Doorn, Carin ^a,c  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b CALDERDALE ROYAL HOSPITAL   (United Kingdom)

^c GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BIOCHEMICAL MARKER; C REACTIVE PROTEIN; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5A; CYCLOPHOSPHAMIDE; CYCLOSPORIN; HYDROCORTISONE; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 8; LEUKOCYTE ELASTASE; METHYLPREDNISOLONE; PREDNISOLONE;

ADULT; AORTA VALVE REGURGITATION; AORTA VALVE REPLACEMENT; ARTICLE; AUTOIMMUNE DISEASE; CARDIOPULMONARY BYPASS; CASE REPORT; CHRONIC INFLAMMATION; CLINICAL OBSERVATION; HEART MUSCLE REVASCULARIZATION; HEMATOLOGICAL PARAMETERS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LEUKOCYTE COUNT; MALE; MEDICAL LITERATURE; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; WEGENER GRANULOMATOSIS;

AORTIC VALVE INSUFFICIENCY; BLOOD VESSEL PROSTHESIS IMPLANTATION; CARDIOPULMONARY BYPASS; COMPLEMENT C3A; COMPLEMENT C5A; HUMANS; IMMUNOSUPPRESSION; INTERLEUKIN-8; LEUKOCYTE ELASTASE; MALE; MIDDLE AGED; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; WEGENER GRANULOMATOSIS;

EID: 2342664955     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1191/0267659104pf726oa     Document Type: Article

References (16)

1. Morelli S, Gurgo Di Castelmenardo AM, Conti F et al. Cardiac involvement in patients with Wegener's granulomatosis. Rheumatol Int 2000; 19: 209-12.
2. Asimakopoulos G. Mechanisms of the systemic inflammatory response. Perfusion 1999; 14: 269-77.
3. Edmunds LH Jr. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 1998; 66: S12-16.
4. Butler J, Parker D, Pillai R, Westaby S, Shale DJ, Rocker GM. Effect of cardiopulmonary bypass on systemic release of neutrophil elastase and tumour necrosis factor. J Thorac Cardiovasc Surg 1993; 105: 25-30.
5. Ascione R, Lloyd C, Underwood MJ, Lotto AA, Pitsis AA, Angelini GD. Inflammatory response after coronary revascularization with or without cardiopulmonary bypass. Ann Thorac Surg 2000; 69: 1198-204.
6. Gu YJ, Mariany MA, van Oeveren W, Grandjean JG, Boonstra PW. Reduction in inflammatory response in patients undergoing minimally invasive coronary artery bypass grafting. Ann Thorac Surg 1998; 65: 420-25.
7. Engelman RM, Rousou JA, Flack JE, Deaton DW, Kalfin R, Das DK. Influence of steroids on complement and cytokine generation after cardiopulmonary bypass. Ann Thorac Surg 1995; 60: 801-804.
8. Gu YJ, de Vries AJ, Boonstra PW, van Oeveren W. Leukocyte depletion results in improved lung function and reduced inflammatory response after cardiac surgery. J Thorac Cardiovasc Surg 1996; 112: 494-500.
9. Persson U, Truedsson L, Westman KW, Segelmark M. C3 and C4 allotypes in anti-neutrophil cytoplasmic autoantibody(ANCA)-positive vasculitis. Clin Exp Immunol 1999; 116: 379-82.
10. Haubitz M, Schulzeck P, Schellong S, Schulze M, Koch KM, Brunkhorst R. Complexed plasma elastase as an in vivo marker for leukocyte activation in antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 1997; 40: 1680-84.
11. Seghaye MC, Duchateau J, Grabitz R et al. Influence of low-dose aprotinin on the inflammatory reaction due to cardiopulmonary bypass in children. Ann Thorac Surg 1996; 61: 1205-11.
12. Ashraf S, Tian Y, Cowan D et al. "Low-dose" aprotinin modifies hemostasis but not proinflammatory cytokine release. Ann Thorac Surg 1997; 63: 68-73.
13. Tassani P, Augustin N, Barankay A, Braun SL, Zaccaria F, Richter JA. High-dose aprotinin modulates the balance between proinflammatory and anti-inflammatory responses during coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 2000; 14: 682-86.
14. Tassani P, Richter JA, Barankay A et al. Does high-dose methylprednisolone in aprotinin-treated patients attenuate the systematic inflammatory responses during CABG procedure? J Cardiothorac Vasc Anesth 1999; 13: 165-72.
15. Markewitz A, Lante W, Franke A, Marohl K, Kuhlmann WD, Weinhold C. Alterations of cell-mediated immunity following cardiac operations: clinical implications and open questions. Shock 2001; 16: 10-15.
16. Buselmeier TJ, Cantieri JS, Dahl MV et al. Clearing of psoriasis after cardiac surgery requiring cardiopulmonary bypass oxygenation: a corollary to clearance after dialysis? Br J Dermatol 1979; 100: 311-13.